Vasopressin Deficiency Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting vasopressin deficiency clinical trials across 3 countries. Studies span Early Phase 1, Phase 2, Not Applicable, Phase 1. Top locations include Boston, Massachusetts, United States, Basel, Switzerland, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Vasopressin Deficiency Trials at a Glance

7 actively recruiting trials for vasopressin deficiency are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Early Phase 1 with 2 trials, with the heaviest enrollment activity in Boston, Basel, and Barcelona. Lead sponsors running vasopressin deficiency studies include University Hospital, Basel, Switzerland, Elizabeth Austen Lawson, and Hospital Universitario 12 de Octubre.

Browse vasopressin deficiency trials by phase

Treatments under study

About Vasopressin Deficiency Clinical Trials

Looking for clinical trials for Vasopressin Deficiency? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vasopressin Deficiency trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vasopressin Deficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

Vasopressin Deficiency
Elizabeth Austen Lawson40 enrolled1 locationNCT04789148
Recruiting
Early Phase 1

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

HypopituitarismArginine vasopressin deficiencyOxytocin Deficiency+1 more
Massachusetts General Hospital20 enrolled1 locationNCT07568509
Recruiting
Not Applicable

Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome

Primary polydipsiaArginine vasopressin deficiency
University Hospital, Basel, Switzerland144 enrolled1 locationNCT07569861
Recruiting
Phase 2

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Arginine vasopressin deficiencyCentral Diabetes InsipidusOxytocin Deficiency
University Hospital, Basel, Switzerland42 enrolled1 locationNCT06808516
Recruiting
Phase 2

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

Arginine vasopressin deficiencyDiabetes Insipidus
University Hospital, Basel, Switzerland42 enrolled1 locationNCT06676774
Recruiting
Early Phase 1

Identifying Oxytocin Deficiency in Adults With Pituitary Disease

Arginine vasopressin deficiencyOxytocin Deficiency
Elizabeth Austen Lawson32 enrolled1 locationNCT06460948
Recruiting

Registry of Patients in Shock Treated With Vasopressin

ShockVasopressin DeficiencyVasopressin Causing Adverse Effects in Therapeutic Use+1 more
Hospital Universitario 12 de Octubre500 enrolled24 locationsNCT06422975